Literature DB >> 24678061

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.

Hamilton Morris1, Jason Wallach.   

Abstract

PCP or phencyclidine was discovered in 1956 and soon became a popular street drug. Dissociatives including PCP, ketamine, and dextromethorphan have been used non-medically for their mind-altering effects for over 60 years. Many of these compounds have also been used clinically and in legitimate research. At least 14 derivatives of PCP were sold for non-medical and illict use from the late 1960s until the 1990s. With the advent of the Internet, the drug market underwent a dramatic evolution. While initially gray-market chemical vendors offering dextromethorphan and ketamine thrived, most recently the market has shifted to legal high and online-based research chemical vendors. Starting with the first dissociative research chemical, 4-MeO-PCP in 2008, the dissociative research chemical market has rapidly evolved and currently comprises at least 12 dissociatives, almost half of which were unknown in the scientific literature prior to their introduction. Several of these, including methoxetamine, have reached widespread use internationally. A historical account of non-medical use of over 30 dissociative compounds was compiled from a diverse collection of sources. The first complete portrait of this underground market is presented along with the relevant legal, technological, and scientific developments which have driven its evolution.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Internet drug forums; NMDA; PCP; arylcyclohexylamines; dissociatives; folk pharmacology; ketamine; methoxetamine; phencyclidine; research chemicals

Mesh:

Substances:

Year:  2014        PMID: 24678061     DOI: 10.1002/dta.1620

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  32 in total

1.  Methoxetamine affects brain processing involved in emotional response in rats.

Authors:  M T Zanda; P Fadda; S Antinori; M Di Chio; W Fratta; C Chiamulera; L Fattore
Journal:  Br J Pharmacol       Date:  2017-08-19       Impact factor: 8.739

2.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

3.  Pharmacological characterizations of the 'legal high' fluorolintane and isomers.

Authors:  Jason Wallach; Tristan Colestock; Julià Agramunt; Matt D B Claydon; Michael Dybek; Nadine Filemban; Muhammad Chatha; Adam L Halberstadt; Simon D Brandt; David Lodge; Zuner A Bortolotto; Adeboye Adejare
Journal:  Eur J Pharmacol       Date:  2019-05-29       Impact factor: 4.432

4.  The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.

Authors:  Adam L Halberstadt; Natalia Slepak; James Hyun; Mahalah R Buell; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2016-01-13       Impact factor: 4.530

Review 5.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

6.  Severe Toxicity to the New Psychoactive Substances 3-Hydroxyphencyclidine and N-Ethylhexedrone: an Analytically Confirmed Case Report.

Authors:  Lisa Christine Dunlop; David Wood; John Archer; Simon Hudson; Paul Dargan
Journal:  J Med Toxicol       Date:  2019-09-03

7.  Phencyclidine-like in vivo effects of methoxetamine in mice and rats.

Authors:  Michael D Berquist; William S Hyatt; Jonathan Bauer-Erickson; Brenda M Gannon; Andrew P Norwood; William E Fantegrossi
Journal:  Neuropharmacology       Date:  2017-08-19       Impact factor: 5.250

Review 8.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

9.  Dextromethorphan in Cough Syrup: The Poor Man's Psychosis.

Authors:  Bridgette Martinak; Ramy A Bolis; Jeffrey Ryne Black; Rachel E Fargason; Badari Birur
Journal:  Psychopharmacol Bull       Date:  2017-09-15

10.  Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.

Authors:  Theresa M Carbonaro; Matthew W Johnson; Ethan Hurwitz; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2017-11-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.